Search results for "Brain Neoplasm"

showing 10 items of 249 documents

The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification.

2008

The ERK1/2 activated protein kinase (MAPK) pathway is a critical signaling system that mediates ligand-stimulated signals for the induction of cell proliferation, differentiation and survival, involved in malignant transformation. The purpose of this study was to determine the activation of ERK1/2 in this tumor, and to determine the relationship of ERK1/2 activation with the amplification/overexpression of EGFR as well as with 9p21 locus gene alterations, both of which are genetic factors frequently associated with glioblastoma. We used immunohistochemistry and Western blot analysis to analyze the activation of ERK1/2 in 22 patients with glioblastoma, and we studied the amplification/overex…

MAPK/ERK pathwayMaleBlotting WesternBiologyPolymerase Chain ReactionPathology and Forensic MedicineMalignant transformationWestern blotmedicineHumansProtein kinase AExtracellular Signal-Regulated MAP KinasesAgedmedicine.diagnostic_testKinaseCell growthBrain NeoplasmsGene AmplificationGeneral MedicineMiddle AgedMolecular biologyImmunohistochemistryEnzyme ActivationErbB ReceptorsImmunohistochemistryFemaleNeurology (clinical)GlioblastomaImmunostainingSignal TransductionNeuropathology : official journal of the Japanese Society of Neuropathology
researchProduct

Non-negative blind source separation techniques for tumor tissue typing using HR-MAS signals.

2010

Given High Resolution Magic Angle Spinning (HR-MAS) signals from several glioblastoma tumor subjects, the goal is to differentiate between tumor tissue types by separating the different sources that contribute to the profile of each spectrum. Blind source separation techniques are applied for obtaining characteristic profiles for necrosis, high cellular tumor and border tumor tissue, and providing the contribution (abundance) of each tumor tissue to the profile of the spectra. The problem is formulated as a non-negative source separation problem. We illustrate the effectiveness of the proposed methods and we analyze to which extent the dimension of the input space could influence the perfor…

Magnetic Resonance SpectroscopyComputer scienceFeature extractionBlind signal separationSensitivity and SpecificitySpectral linePattern Recognition AutomatedNuclear magnetic resonanceDimension (vector space)medicineSource separationMagic angle spinningBiomarkers TumorHumansTypingDiagnosis Computer-Assistedmedicine.diagnostic_testArtificial neural networkbusiness.industryBrain NeoplasmsReproducibility of ResultsMagnetic resonance imagingPattern recognitionmedicine.diseaseTumor tissueArtificial intelligencebusinessGlioblastomaAlgorithmsGlioblastoma
researchProduct

Quantification and classification of high-resolution magic angle spinning data for brain tumor diagnosis.

2007

The goal of this work is to propose a complete protocol (preprocessing, processing and classification) for classifying brain tumors with proton high-resolution magic-angle spinning ((1)H HR-MAS) data. The different steps of the procedure are detailed and discussed. Feature extraction techniques such as peak integration, including also the automated quantitation method AQSES, were combined with linear (LDA) and non-linear (least-squares support vector machine or LS-SVM) classifiers. Classification accuracy was assessed using a stratified random sampling scheme. The results suggest that LS-SVM performs better than LDA while AQSES performs better than the standard peak integration feature extr…

Magnetic Resonance SpectroscopyProtonComputer scienceFeature extractionBrain tumorHigh resolutionSensitivity and SpecificityLeast squares support vector machineBiomarkers TumorMagic angle spinningmedicineHumansDiagnosis Computer-AssistedSpinningBrain Neoplasmsbusiness.industryMagic (programming)Reproducibility of ResultsPattern recognitionNuclear magnetic resonance spectroscopymedicine.diseaseSupport vector machineComputingMethodologies_PATTERNRECOGNITIONSpin LabelsArtificial intelligenceProtonsbusinessAlgorithms
researchProduct

A Novel Semi-Supervised Methodology for Extracting Tumor Type-Specific MRS Sources in Human Brain Data

2013

Background: The clinical investigation of human brain tumors often starts with a non-invasive imaging study, providing \ud information about the tumor extent and location, but little insight into the biochemistry of the analyzed tissue. Magnetic \ud Resonance Spectroscopy can complement imaging by supplying a metabolic fingerprint of the tissue. This study analyses \ud single-voxel magnetic resonance spectra, which represent signal information in the frequency domain. Given that a single \ud voxel may contain a heterogeneous mix of tissues, signal source identification is a relevant challenge for the problem of\ud tumor type classification from the spectroscopic signal.\ud Methodology/Princ…

Magnetic Resonance SpectroscopyStatistics as TopicBioinformaticsSignalDiagnostic RadiologyEngineeringDiscriminative modelBasic Cancer ResearchMathematical ComputingNeurological TumorsComplement (set theory)PhysicsMultidisciplinaryBrain NeoplasmsApplied MathematicsQRBrainMagnetic Resonance ImagingIdentification (information)OncologyFrequency domainMetric (mathematics)MedicineRadiologyAlgorithmsResearch ArticleScienceLipid signalingGlioblastoma multiformeMatrix decompositionRC0254Magnetic resonance imagingCancer detection and diagnosisMagnetic resonance spectroscopyCancer Detection and DiagnosisHumansPrototypesbusiness.industryFingerprint (computing)Cancers and NeoplasmsData acquisitionPattern recognitionComputing MethodsR1Computer ScienceSignal ProcessingRC0321Artificial intelligencebusinessMathematics
researchProduct

Prognostic Implications of the Complement Protein C1q in Gliomas

2019

The contribution of the complement system in the pathophysiology of brain cancers has been recently considered in light of its well-known involvement in carcinogenesis. Complement system represents an important component of the inflammatory response, which acts as a functional bridge between the innate and adaptive immune response. C1q, the first recognition subcomponent of the complement classical pathway, has recently been shown to be involved in a range of pathophysiological functions that are not dependent on complement activation. C1q is expressed in the microenvironment of various types of human tumors, including melanoma, prostate, mesothelioma, and ovarian cancers, where it can exer…

Male0301 basic medicinemedicine.disease_causePathogenesisbioinformatics analysis; C1q complement; gliomas; prognostic significance of C1q; survival probability0302 clinical medicinegliomaTumor MicroenvironmentImmunology and AllergyComplement C1qbioinformatics analysiOriginal ResearchSettore MED/27 - NeurochirurgiaBrain NeoplasmsMelanomaBioinformatics analysiGliomaPrognosisAcquired immune systemNeoplasm ProteinsGene Expression Regulation NeoplasticBioinformatics analysisFemalePrognostic significance of C1q.Databases Nucleic Acidlcsh:Immunologic diseases. Allergybioinformatics analysisImmunologyprognostic significance of C1qBiology03 medical and health sciencesClassical complement pathwayC1q complementGliomaBiomarkers TumormedicineHumanssurvival probabilitySurvival probabilityGliomasC1q complementComplement C1qmedicine.diseaseComplement systemgliomas030104 developmental biologyCancer researchlcsh:RC581-607Carcinogenesis030215 immunologyFrontiers in Immunology
researchProduct

Tumor Diagnosis Preceding Alzheimer's Disease Onset: Is There a Link Between Cancer and Alzheimer's Disease?

2012

Studies reporting an inverse association between Alzheimer's disease (AD) and cancer are scant. Available data are mostly based on ancillary findings of mortality data or obtained from studies evaluating frequency of neoplasms in AD patients independently if they occurred before or after AD. Moreover, some studies estimated frequencies of neoplasms in demented individuals, who were not necessarily AD patients. We estimated frequency of tumors preceding the onset of AD in AD patients and compared it to that of age- and gender-matched AD-free individuals. Occurrence of tumors preceding AD onset was assessed through a semi-structured questionnaire. Tumors were categorized as benign, malignant,…

MaleAlzheimer's disease cancer epidemiologyOncologymedicine.medical_specialtyDiseaseAssociationSex FactorsAlzheimer DiseaseRisk FactorsInternal medicineEpidemiologyOdds RatiomedicineHumansAge of OnsetAgedRetrospective StudiesAged 80 and overBrain Neoplasmsbusiness.industryGeneral NeuroscienceCase-control studyCancerRetrospective cohort studyGeneral MedicineOdds ratiomedicine.diseasePsychiatry and Mental healthClinical PsychologyCase-Control StudiesDisease ProgressionFemaleSettore MED/26 - NeurologiaGeriatrics and GerontologyAlzheimer's diseaseAge of onsetbusinessJournal of Alzheimer's Disease
researchProduct

Maternal medication use and the risk of brain tumors in the offspring: The SEARCH international case-control study

2006

International audience; N-nitroso compounds (NOC) have been associated with carcinogenesis in a wide range of species, including humans. There is strong experimental data showing that nitrosamides (R(1)NNO.COR(2)), a type of NOC, are potent neuro-carcinogens when administered transplacentally. Some medications are a concentrated source of amides or amines, which in the presence of nitrites under normal acidic conditions of the stomach can form NOC. Therefore, these compounds, when ingested by women during pregnancy, may be important risk factors for tumors of the central nervous system in the offspring. The aim of the present study was to test the association between maternal use of medicat…

MaleCancer ResearchMESH: Maternal-Fetal ExchangeMESH: Pregnancy0302 clinical medicinePregnancyRisk FactorsMESH: Risk FactorsMESH: ChildRecall biasEpidemiologyMedicine030212 general & internal medicineAminesChildMaternal-Fetal Exchangeeducation.field_of_studyBrain NeoplasmsN-nitroso compoundsMESH: AminesMESH: InfantMESH: AmidesMESH: Case-Control StudiesMESH: Mothers3. Good healthOncologyChild Preschool030220 oncology & carcinogenesisMESH: Brain NeoplasmsFemaleDisease SusceptibilityAdultmedicine.medical_specialtyAdolescentOffspringcase-control studyPopulationMESH: Disease SusceptibilityMothers[SDV.CAN]Life Sciences [q-bio]/Cancerchildhood brain tumors03 medical and health sciencesInternal medicineGliomamaternal medicationHumansRisk factoreducationMESH: AdolescentPregnancyMESH: Humansbusiness.industryMESH: Child PreschoolCase-control studyInfantMESH: Adultmedicine.diseaseAmidesMESH: MaleCase-Control StudiesbusinessMESH: FemaleInternational Journal of Cancer
researchProduct

Risk factors for pediatric tumors of the central nervous system: Results from a German population-based case-control study

2001

From 1993 to 1997 we conducted two population-based case-control studies on childhood cancer and a variety of potential risk factors in Germany. One case group involved children under the age of 15 years having a tumor of the central nervous system (CNS).For both studies, one conducted in the northwestern area of Germany, the other covering the whole of West Germany, incident cases were identified from the nationwide German Childhood Cancer Registry, and controls were randomly selected from complete population registration files.In total 466 pediatric CNS tumor cases and 2,458 controls were available for analyses. We observed only few positive associations, namely, between CNS tumors and lo…

MaleCancer ResearchPediatricsmedicine.medical_specialtyAdolescentBirth weightPopulationFetusPregnancyRisk FactorsEpidemiologymedicineHumansRisk factorChildeducationeducation.field_of_studyPregnancyChildhood Cancer RegistryBrain Neoplasmsbusiness.industryInfant NewbornInfantmedicine.diseaseRadiographyLow birth weightOncologyCase-Control StudiesChild PreschoolPediatrics Perinatology and Child HealthFemalemedicine.symptombusinessBreast feedingMaternal AgeMedical and Pediatric Oncology
researchProduct

Population-based epidemiologic data on brain tumors in German children.

2001

BACKGROUND Brain tumors are the most common disease group of solid tumors in childhood, and children with brain tumors have a relatively poor survival rate. Epidemiologic data from a population-based cancer registry provide the necessary information to obtain a full picture of the frequency of this disease, which is a great challenge in pediatric oncology. METHODS The German Childhood Cancer Registry (GCCR) is a population-based registry. The level of completeness of patient registration is 95%, but it is somewhat lower for patients with brain tumors. More than 300 children with newly diagnosed brain tumors are reported every year. Analyses of GCCR data are performed according to the Intern…

MaleCancer ResearchPediatricsmedicine.medical_specialtyAdolescentPopulationCentral nervous system diseaseGermanymedicineHumansRegistriesAge of OnseteducationChildSurvival rateeducation.field_of_studyChildhood Cancer Registrybusiness.industryBrain NeoplasmsIncidence (epidemiology)IncidenceInfant NewbornCancerInfantmedicine.diseasePrognosisSurvival AnalysisCancer registryEpidemiologic StudiesOncologyChild PreschoolFemaleGerm cell tumorsbusinessCancer
researchProduct

Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hemat…

2004

BACKGROUND Continuous oral treatment with topotecan may be more effective than the typical 1-day and 5-day treatment schedules. In previous studies of continuous treatment with topotecan, increased intestinal side effects were reported in adult patients; however, the experience in pediatric patients and patients with high-grade glioma is quite limited. METHODS Thirty-two pediatric patients with recurrent high-grade glioma (16 females and 16 males; median age, 9.5 years) were enrolled in the current Phase I/II study. Tumor locations included the cerebral cortex (n = 5), pons (n = 18), and other sites (n = 9). An injectable formulation of topotecan was administered orally, in ice-cold orange …

MaleCancer Researchmedicine.medical_specialtyAdolescentAdministration OralAntineoplastic AgentsGastroenterologyDrug Administration Schedule03 medical and health sciences0302 clinical medicinePharmacokineticsOral administrationInternal medicineGliomaMedicineHumansDosingChild030304 developmental biologyOrange juice0303 health sciencesbusiness.industryBrain NeoplasmsGliomamedicine.disease3. Good healthSurgeryTreatment OutcomeOncology030220 oncology & carcinogenesisChild PreschoolToxicityTopotecanFemalebusinessTopotecanProgressive diseasemedicine.drugCancer
researchProduct